Fundamentals

Anbio Biotechnology

NNNN

Soon

Sentiment

Soon

Options

Revenue

8.19M

▲1.47M▲21.95%

12 Months Change

Assets

18.92M

▲3.11M▲19.67%

12 Months Change

Liabilities

1.73M

▲737.17k▲74.23%

12 Months Change

Free Cash Flow

0.00

0.000.00%

-

Revenue/Cost Of Revenue

Quarterly

Net Profit/Loss

Quarterly

Assets/Liabilities

Quarterly

Cash Flows

Quarterly

Quarterly

Outstanding Shares

Quarterly

Recent Quarterly and Annual Filings

ID: 0001213900-25-035802